Your browser doesn't support javascript.
loading
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.
Saal, Lao H; Vallon-Christersson, Johan; Häkkinen, Jari; Hegardt, Cecilia; Grabau, Dorthe; Winter, Christof; Brueffer, Christian; Tang, Man-Hung Eric; Reuterswärd, Christel; Schulz, Ralph; Karlsson, Anna; Ehinger, Anna; Malina, Janne; Manjer, Jonas; Malmberg, Martin; Larsson, Christer; Rydén, Lisa; Loman, Niklas; Borg, Åke.
Afiliação
  • Saal LH; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, SE-22381 Lund, Sweden.
  • Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, SE-22381 Lund, Sweden.
  • Häkkinen J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, SE-22381 Lund, Sweden.
  • Hegardt C; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, SE-22381 Lund, Sweden.
  • Grabau D; Department of Pathology, Skåne University Hospital, SE-22185 Lund, Sweden.
  • Winter C; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden.
  • Brueffer C; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden.
  • Tang MH; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden.
  • Reuterswärd C; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Clinical Sciences, SCIBLU Genomics, Lund University, SE-22381 Lund, Sweden.
  • Schulz R; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Clinical Sciences, SCIBLU Genomics, Lund University, SE-22381 Lund, Sweden.
  • Karlsson A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Clinical Sciences, SCIBLU Genomics, Lund University, SE-22381 Lund, Sweden.
  • Ehinger A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Pathology and Cytology, Blekinge County Hospital, SE-37185 Karlskrona, Sweden.
  • Malina J; Department of Pathology, Skåne University Hospital, SE-20502 Malmö, Sweden.
  • Manjer J; Department of Surgery, Lund University and Skåne University Hospital, SE-20502 Malmö, Sweden.
  • Malmberg M; Department of Oncology, Skåne University Hospital, SE-22185 Lund, Sweden.
  • Larsson C; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Laboratory Medicine, Division of Molecular Pathology, Lund University, SE-22185 Lund, Sweden.
  • Rydén L; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Surgery, Lund University and Skåne University Hospital, SE-22185 Lund, Sweden.
  • Loman N; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; Department of Oncology, Skåne University Hospital, SE-22185 Lund, Sweden.
  • Borg Å; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2, SE-22381 Lund, Sweden ; Lund University Cancer Center, SE-22381 Lund, Sweden ; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, SE-22381 Lund, Sweden ; Depa
Genome Med ; 7(1): 20, 2015.
Article em En | MEDLINE | ID: mdl-25722745
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Genome Med Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Genome Med Ano de publicação: 2015 Tipo de documento: Article